DF1001

Phase I/II study of DF1001 Trinket immunotherapy for HER2 expressing tumors: Open cohorts are for breast cancer, colon cancer and NSCLC
Status:

Open

Trial Type:
Breast Cancer, Colon Cancer, Early Phase Trials for Multiple Cancer Types, Lung Cancer

Contact:

Dr. Benedito Carneiro
Benedito.carneiro@lifespan.org

©2023 Brown Cancer Clinical Trials